Bluesky Feed - Breast Cancer

In the feed right now

Live from Bluesky

USA TODAY @usatoday.com · about 2 hours ago

"The Challenge" and "Real World" star Anika Rashaun has died at the age of 34 after a battle with stage 4 breast cancer.

bit.ly

'The Challenge' alum Anika Rashaun dies at 34 after breast cancer battle

"The Challenge" and "Real World" star Anika Rashaun has died at the age of 34 after a battle with stage 4 breast cancer.

1 1 6

WHRO Public Media @whropublicmedia.bsky.social · about 4 hours ago

BraZazzle at Sentara Princess Anne Hospital in Virginia Beach and Bra-Ha-Ha at Chesapeake Regional Healthcare invite survivors, people living with the disease and the public to decorate bras and share the stories behind their creations.

www.whro.org

Medical centers use cups of creativity to raise breast cancer awareness

Two art contests, BraZazzle and Bra-Ha-Ha, invite people to use bras as canvases to tell stories of survival and hope. The public can still vote on favorites and donate money.

0 0 0

@wsmv.com · about 4 hours ago

Young breast cancer survivor in Nashville urges women under 40 to self-check

www.wsmv.com

Young breast cancer survivor in Nashville urges women under 40 to self-check

A 24-year-old Nashville woman shares how she was diagnosed with breast cancer before her wedding, completed treatment, and is now cancer free, prompting a reminder that young women should perform self exams.

0 1 2

bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · about 4 hours ago

ANO6 Scaffolds ER Mitochondria Contacts to Govern Spatial Lipid Compartmentalization and Ferroptosis Evasion in Chemoresistant Breast Cancer www.biorxiv.org/content/1…

0 1 1

Susan G. Komen @susangkomen.bsky.social · about 6 hours ago

What helps bring groundbreaking ideas from the lab to the clinic? #Clinicaltrials. This year, Komen funded over $15 million in grants supporting new research, including lifesaving clinical trials. Learn about three of the questions these trials are asking to change the future of breast cancer care.

0 0 1

Cancer Therapy Advisor @cancertherapyadv.bsky.social · about 6 hours ago

NATALEE: Adjuvant Ribociclib Plus NSAI Improves Long-Term Survival in HR+/HER2- Early Breast Cancer Ribociclib plus NSAI therapy was associated with significant improvement in OS, at a rate of 91.9% at 6 years compared to 89.7% with NSAI alone #ESMO26 🔗 bit.ly/4jySLyB

0 0 0

Applied Radiation Oncology @appliedradoncology.bsky.social · about 7 hours ago

🩻 Case Study of the Week - Diagnosis Time! EHE with R0 resection and multifocal pT2N0 (i+) right breast cancer (ER 90%, PR 95%, HER2 DISH negative) 🔗 See all the case details, more images, and the diagnosis: zurl.co/vPYyi

0 0 0

OncLive @onclive.bsky.social · about 7 hours ago

Adjuvant giredestrant sustained physical functioning, role functioning, and HRQOL and was associated with sustained low AE bother vs SOC in ER+, HER2– early breast cancer, according to PROs from lidERA Breast Cancer. @myesmo.bsky.social #ESMO2026 #bcsm #oncology www.onclive.com/view/adju….

0 0 0

RadiologyInfo.org @radiologyinfo.bsky.social · about 7 hours ago

“If you don’t do it, no one else will.” Hear why Carrie has gotten a #Mammogram every year since age 40, and why she wants you to do the same 👉 tinyurl.com/43w888am #BreastCancerAwareness #RadiologyInfo

0 0 0

Tufts University School of Medicine @tuftsmedschool.bsky.social · about 10 hours ago

Using 3D organoid models, researchers at Tufts University School of Medicine found that exposure to certain chemicals may alter normal breast tissue development, leaving molecular changes that could help identify people at higher risk of breast cancer. ow.ly/B68m50ZZ2mw

0 0 0

Keep reading on Bluesky